Additionally, the authors developed a predictive flow cytometric score for venetoclax response including B markers (CD20, CD79A) used to detect venetoclax-sensitive myeloma without relying on t(11;14) (68). The gene discussed is CD79A; the disease is plasma cell myeloma.